Monthly Archives: January 2011

Weekly Roundup 1/7/11

Posted on January 7, 2011 by Mark Senak

Happy New Year. Though it is one of those weeks that is always tinged with a little sadness, isn’t it?  The Christmas trees, once adorned and adored, lie like derelicts along side roads or at the curb in haunting darkness … Continue reading →

Posted in Uncategorized | 2 Comments

Dr. Sharfstein’s Departure

Posted on January 6, 2011 by Mark Senak

This week, the news came out, ironically via Twitter, that Dr. Joshua Sharfstein was going to be departing as Deputy Commissioner from the FDA, effective almost immediately, to take on duties at the state level in Maryland.  When he and … Continue reading →

Posted in Uncategorized | 2 Comments

Pharma TWANK (Twitter Rankings) 2011

Posted on January 5, 2011 by Mark Senak

TWANK.  I made it up.  Stands for Twitter Ranking.  Just before Christmas, I wrote a post that reviewed pharma YouTube channels and assessed how they are doing.  There, for the most part, it did not seem that the industry has … Continue reading →

Posted in New and Social Media | 15 Comments

FDA AdComm Calendar for 2011 – Where is the Action?

Posted on January 4, 2011 by Mark Senak

At nearly the end of 2010, the FDA published the tentative calendar for advisory committee meetings for 2011.  Naturally, the agency cannot precisely detail the calendar at this stage, but it does provide a bit of a signal regardomg the … Continue reading →

Posted in Advisory Committee Prepapartion, Uncategorized | 3 Comments

Things to Look for in 2011

Posted on January 3, 2011 by Mark Senak

Well, everyone is either doing their look-back or look-forward thing.  The future is more interesting than the past, so here is the Eye on FDA list of things to look for this year: Oversight, Oversight, Oversight – The FDA never … Continue reading →

Posted in FDA Policy | Comments Off on Things to Look for in 2011